Trial
NCT03539484
A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Hoffmann-La Roche
Collaborators
—
Condition
Solid Tumors
Intervention
RO7172508
Why stopped
Study terminated due to change in benefit-risk ratio, driven by high incidence GI toxicity in absence of clinically significant anti-tumor efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-03